181 related articles for article (PubMed ID: 16904838)
21. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
[TBL] [Abstract][Full Text] [Related]
22. The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer.
Li Q; Liu Y; Su B; Zhao H; Lin Q; Zhu Y; Zhang L; Weng D; Gong X; Sun X; Xu Y
Transl Lung Cancer Res; 2020 Jun; 9(3):713-721. PubMed ID: 32676333
[TBL] [Abstract][Full Text] [Related]
23. A new approach to quantifying lung damage after stereotactic body radiation therapy.
Palma DA; van Sörnsen de Koste JR; Verbakel WF; Senan S
Acta Oncol; 2011 May; 50(4):509-17. PubMed ID: 21174519
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance.
Aoki T; Nagata Y; Negoro Y; Takayama K; Mizowaki T; Kokubo M; Oya N; Mitsumori M; Hiraoka M
Radiology; 2004 Jan; 230(1):101-8. PubMed ID: 14645881
[TBL] [Abstract][Full Text] [Related]
25. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
Vinogradskiy Y; Diot Q; Kavanagh B; Schefter T; Gaspar L; Miften M
Med Phys; 2013 Aug; 40(8):081712. PubMed ID: 23927309
[TBL] [Abstract][Full Text] [Related]
26. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer.
Ueki N; Matsuo Y; Togashi Y; Kubo T; Shibuya K; Iizuka Y; Mizowaki T; Togashi K; Mishima M; Hiraoka M
J Thorac Oncol; 2015 Jan; 10(1):116-25. PubMed ID: 25376512
[TBL] [Abstract][Full Text] [Related]
27. CT Appearance Pattern After Stereotactic Body Radiation Therapy Predicts Outcomes in Early-Stage Non-Small-Cell Lung Cancer.
Yang Y; Li G; Li S; Wang Y; Zhao Y; Dong B; Wang J; Zhu R; Chen M
Front Oncol; 2021; 11():746785. PubMed ID: 34707992
[TBL] [Abstract][Full Text] [Related]
28. Suggestion for a new grading scale for radiation induced pneumonitis based on radiological findings of computerized tomography: correlation with clinical and radiotherapeutic parameters in lung cancer patients.
Kouloulias V; Zygogianni A; Efstathopoulos E; Victoria O; Christos A; Pantelis K; Koutoulidis V; Kouvaris J; Sandilos P; Varela M; Aytas I; Gouliamos A; Kelekis N
Asian Pac J Cancer Prev; 2013; 14(5):2717-22. PubMed ID: 23803021
[TBL] [Abstract][Full Text] [Related]
29. Lung deformations and radiation-induced regional lung collapse in patients treated with stereotactic body radiation therapy.
Diot Q; Kavanagh B; Vinogradskiy Y; Garg K; Gaspar L; Miften M
Med Phys; 2015 Nov; 42(11):6477-87. PubMed ID: 26520737
[TBL] [Abstract][Full Text] [Related]
30. Is severe emphysema, as defined by quantitative CT measurement, a negative risk factor of radiation fibrosis?
Saito T; Nakayama H; Yamada T; Shiraishi S; Tokuuye K
Br J Radiol; 2018 Jul; 91(1087):20170921. PubMed ID: 29651875
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.
Harder EM; Park HS; Nath SK; Mancini BR; Decker RH
Pract Radiat Oncol; 2015; 5(6):e643-9. PubMed ID: 26412341
[TBL] [Abstract][Full Text] [Related]
32. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
[TBL] [Abstract][Full Text] [Related]
33. Diabetes mellitus and radiation induced lung injury after thoracic stereotactic body radiotherapy.
Kalman NS; Hugo GD; Mahon RN; Deng X; Mukhopadhyay ND; Weiss E
Radiother Oncol; 2018 Nov; 129(2):270-276. PubMed ID: 30253874
[TBL] [Abstract][Full Text] [Related]
34. Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Dahele M; Palma D; Lagerwaard F; Slotman B; Senan S
J Thorac Oncol; 2011 Jul; 6(7):1221-8. PubMed ID: 21623237
[TBL] [Abstract][Full Text] [Related]
35. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.
Hayes JT; David EA; Qi L; Chen AM; Daly ME
Clin Lung Cancer; 2015 Sep; 16(5):379-84. PubMed ID: 25737143
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary injury from proton and conventional radiotherapy as revealed by CT.
Bush DA; Dunbar RD; Bonnet R; Slater JD; Cheek GA; Slater JM
AJR Am J Roentgenol; 1999 Mar; 172(3):735-9. PubMed ID: 10063871
[TBL] [Abstract][Full Text] [Related]
37. The Fate of Residual Tumor Masses That Persist After Stereotactic Body Radiotherapy for Solitary Lung Nodules: Will They Recur?
Takenaka R; Shibamoto Y; Miyakawa A; Hashizume C; Baba F
Clin Lung Cancer; 2016 Sep; 17(5):406-411. PubMed ID: 26781347
[TBL] [Abstract][Full Text] [Related]
38. Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy.
Hirose TA; Arimura H; Ninomiya K; Yoshitake T; Fukunaga JI; Shioyama Y
Sci Rep; 2020 Nov; 10(1):20424. PubMed ID: 33235324
[TBL] [Abstract][Full Text] [Related]
39. Imaging after radiation therapy of thoracic tumors.
Ghaye B; Wanet M; El Hajjam M
Diagn Interv Imaging; 2016 Oct; 97(10):1037-1052. PubMed ID: 27567554
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
